PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.82%
R&D change of 6.82% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-13.19%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
No Data
No Data available this quarter, please select a different quarter.
-1.40%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-2.45%
Operating expenses reduction while Healthcare median is 3.97%. Seth Klarman would investigate advantages.
-2.45%
Total costs reduction while Healthcare median is 4.65%. Seth Klarman would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
-1.40%
D&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency.
-13.13%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
2.45%
Income change of 2.45% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
49.45%
Other expenses change of 49.45% versus flat Healthcare. Walter Schloss would verify control.
10.71%
Income change of 10.71% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.71%
Income change of 10.71% versus flat Healthcare. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
23.59%
EPS change of 23.59% versus flat Healthcare. Walter Schloss would verify quality.
23.59%
Diluted EPS change of 23.59% versus flat Healthcare. Walter Schloss would verify quality.
16.70%
Share count change of 16.70% versus stable Healthcare. Walter Schloss would verify approach.
16.70%
Diluted share change of 16.70% versus stable Healthcare. Walter Schloss would verify approach.